Opioid Switching from Morphine to Methadone Causes a Minor But Not Clinically Significant Increase in QTc Time: A Prospective 9-Month Follow-Up Study

Introduction. We studied whether primary care teams respond to financial group bonuses by improving the recording of diagnoses, whether this intervention leads to diagnoses reflecting the anticipated distribution of diseases, and how the recording of a significant chronic disease, diabetes, alters after the application of these bonuses. Methods. We performed an observational register-based retrospective quasi-experimental follow-up study with before-and-after setting and two control groups in primary healthcare of a Finnish town. We studied the rate of recorded diagnoses in visits to general practitioners with interrupted time series analysis. The distribution of these diagnoses was also recorded. Results. After group bonuses, the rate of recording diagnoses increased by 17.9% (95% CI: 13.6–22.3) but not in either of the controls (−2.0 to −0.3%). The increase in the rate of recorded diagnoses in the care teams varied between 14.9% (4.7–25.2) and 33.7% (26.6–41.3). The distribution of recorded diagnoses resembled the respective distribution of diagnoses in the former studies of diagnoses made in primary care. The rate of recorded diagnoses of diabetes did not increase just after the intervention. Conclusions. In primary care, the completeness of diagnosis recording can be, to varying degrees, influenced by group bonuses without guarantee that recording of clinically significant chronic diseases is improved.

Download Full-text

Souběžná validita dotazníku SPARO a MMPI 2

E-psychologie ◽

10.29364/epsy.392 ◽

2021 ◽

Vol 15 (1) ◽

pp. 16-39

Author(s):

Hynek Cígler ◽

◽

Adéla Rudá

Keyword(s):

Internal Consistency ◽

Validation Studies ◽

Empirical Support ◽

General Factor ◽

Divergent Validity ◽

Follow Up Study ◽

Main Components ◽

A Minor ◽

Regular Practice

In the previous study (Cígler & Rudá, 2021), we were not able to confirm satisfactory internal consistency and factor validity of the SPARO questionnaire. However, further psychometric properties are also necessary to consider the questionnaire's validity and usefulness in practice. In this follow up study, we examined its criterion validity to MMPI-2, which is used globally and thus has broader empirical support. Despite that, we did not find any support for neither convergent nor divergent validity of the main components, general factor, and the credibility score (L) of SPARO questionnaire to selected MMPI-2 scales. The only exception was the emotional variability scale (EM). As a minor result, we also examined the internal consistency and factor validity of MMPI-2 scales as no other Czech study concerning the questionnaire exists. Neither reliability nor factor validity was satisfactory. Finally, we argue that using the SPARO questionnaire in regular practice cannot be recommended. Cautious use of the MMPI-2 is possible, regarding international validation studies, however, further Czech research is needed, especially in the predictive validity.

Download Full-text